The gene encoding perfringolysin 0, the thiol-activated hemolysin from Clostridium perfringens (ATCC 13124), was cloned and expressed in Escherichia coli. A gene library of C. perfringens chromosomal DNA was constructed in bacteriophage XEMBL3. A recombinant was identified that produced a hemolysin that was inhibited by cholesterol and was tentatively identified as perfringolysin 0. Subcloning experiments localized the perfringolysin 0 gene (pfo) to a 1.8-kilobase region on the cloned chromosomal fragment. E. coli which carried a plasmid subclone of pfo (pRT1B) expressed perfringolysin 0 and secreted it into the periplasm. The amino-terminal sequence of the pfo gene product was identical with that determined for perfringolysin 0 purified from C. perfringens, indicating that E. coli correctly removed the signal peptide during secretion. Purification of the pfo product was accomplished by high-resolution gel filtration and anion-exchange chromatography. Analysis of the pfo product by sodium dodecyl sulfate gel electrophoresis showed that it comigrated with authentic perfringolysin 0; both had an estimated molecular weight of 54,000. Twodimensional tryptic peptide maps of the pfo product and of authentic perfringolysin 0 purified from C. perfringens were identical. The hemolytic activity of the pfo product was similar to that of authentic perfringolysin 0; one hemolytic unit (HU) of the cloned gene product or authentic perfringolysin 0 corresponded to approximately 1 ng or a hemolytic activity of 106 HU per mg.
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Thiol-activated cytolysins are produced by several grampositive bacteria which include Clostridium, Streptococcus, Bacillus, and Listeria species. These cytolysins all share common traits; they are all reversibly inactivated by oxidation and inhibited by small amounts of cholesterol and share common epitopes (3, 15) . In general, the mechanism of action at the molecular level and the structure and function relationships of these cytolysins still remain largely unknown. At least eight thiol-activated cytolysins have been identified in the clostridia (3) . Except for the cytolysin from Clostridium perfringens, perfringolysin 0 (theta-toxin) (19) , most of the clostridial cytolysins have not been purified or characterized. The extent of structural homology among the clostridial thiol-activated cytolysins with those from the other genera is unknown.
The contribution of the thiol-activated cytolysins to the disease process resulting from infection with C. perfringens is unclear; however, their potential to affect cellular function and to cause tissue necrosis suggests a role in the disease process. In gas gangrene, in which C. perfringens is isolated in 80% of the cases (13) , there is a well-demarcated zone of tissue necrosis (12) . No polymorphonuclear leukocytes (PMNLs) are found within this zone, but they are present at the border of the necrotic tissue and found to have an altered morphology and karyolysis. Recently, Stevens et al. (16) showed that low concentrations (nonlytic) of perfringolysin O caused morphological changes in PMNLs, inhibited PMNL chemiluminescence, and reduced random and directed migration of the PMNLs (16) . In contrast, alpha-toxin did not significantly alter any of the PMNL characteristics. The authors stated (16) that the concentrations of perfringolysin 0 used in their study were significantly less than that found in the exudate from experimental gas gangrene in goats in the studies of Noyes et al. (9) . These observations are consistent with the notion that theta-toxin may play a role in localized tissue destruction and the inhibition or destruction of certain cells of the immune system in C.
perfringens-related gas gangrene.
To facilitate further studies of the molecular events during cell lysis by perfringolysin 0 and its role in disease, I have cloned and expressed the gene for perfringolysin 0 in Escherichia coli. The product of the cloned perfringolysin 0 gene produced in E. coli was purified and characterized. Gel electrophoresis. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by the method of Laemmli (6) . A 10% separating gel was used in all instances.
MATERIALS AND METHODS
Purification of perfringolysin 0 from C. perfringens. C.
perfringens ATCC 13124 was grown for 18 h at 37°C in a static culture of brain heart infusion broth. The cells and supernatant from a 6-liter culture of C. perfringens ATCC 13124 were separated by centrifugation, and the perfringolysin 0-containing supernatant fluid was saved. The supernatant was concentrated to 70 ml and pressure dialyzed against 1 liter of 10 mM Tris hydrochloride (buffer A) (pH 8.0) in a tangential-flow Millipore Minitan concentrator (Millipore Corp., Bedford, Mass.). The concentrated supernatant was applied to a solid-matrix Zetachrome anion-exchange column (CUNO, Meriden, Conn.) equilibrated in buffer A. The perfringolysin 0 was eluted with a linear gradient (400 ml) of 0 to 0.2 M NaCl in buffer A. The perfringolysin 0 eluted from the column at approximately 0.1 M NaCl. The perfringolysin 0 was concentrated by ultrafiltration and applied to an Accell QMA (Millipore) anion-exchange column (1.5 cm by 15 cm). The perfringolysin 0 was eluted by a linear gradient (200 ml) of 0 to 0.2 M NaCl in buffer A. The perfringolysin 0 fractions were pooled and reduced with 30 mM DTT and the excess DTT was removed by chromatography over Sephadex G-50F. The reduced toxin preparation was applied to a 2-ml column of thiopropyl Sepharose (Pharmacia, Piscataway, N.J.), and the unbound protein was eluted with 10 mM Tris hydrochloride (pH 8.0)-100 mM NaCl. Perfringolysin 0 was bound to this column via its essential cysteine and was eluted with buffer A containing 30 mM DTT. The perfringolysin 0 was applied to a highresolution anion-exchange column (Mono Q; Pharmacia, Piscataway, N.J.) and eluted with a linear gradient (30 ml) from 0 to 0.2 M NaCl in buffer A. The final preparation of perfringolysin 0 gave a single band on SDS-PAGE, a single peak on the high-resolution Mono Q anion-exchange column, and a single peak on the high-resolution Superose 12 (Pharmacia, Piscataway, N.J.) gel filtration column.
Purification of the perfringolysin 0 gene product from E. on October 28, 2017 by guest http://iai.asm.org/ Downloaded from cells were separated from the spent media by centrifugation, suspended in 100 ml of TE, and pelleted by centrifugation. The periplasmic proteins were released by the cold-osmoticshock method of Neu and Heppel (8). The cell pellet was washed twice in TE and then suspended in 40 ml of TE containing 20% sucrose. After 10 min, the cells were pelleted, the supernatant was discarded, and the cell pellet was rapidly mixed with 1 liter of ice-cold distilled water. The two cell washes and the periplasmic proteins released by the cold osmotic shock were pooled and concentrated by tangential flow ultrafiltration. As described above, E. coli producing elevated levels of the perfringolysin 0, as a result of the IPTG induction of the lac promoter, tended to become osmotically unstable, and much of the hemolysin was released by simply washing the cells in the TE; therefore, the washes were combined with the shock fluid. The crude mixture was applied to a column (1.5 cm by 10 cm) packed with an anion-exchange matrix (Accell QMA; Millipore). The bound proteins were eluted with a linear gradient (200 ml) of 0 to 0.2 M NaCl in buffer A. The fractions which contained the hemolytic activity were pooled, concentrated, and applied to a high-resolution Superose 12 gel filtration column. The fractions which contained the hemolytic activity were pooled, concentrated and applied to a Mono Q column. The column was developed with a linear gradient (30 ml) from 0 to 0.2 M NaCl in buffer A. The perfringolysin O eluted at approximately 0.08 M NaCl. The E. coliproduced perfringolysin 0 was homogeneous as determined by SDS-PAGE. Also, no other proteins were detected during the sequencing of the amino terminus. If contaminating proteins were present, then each step in the sequence analysis would have yielded more than one residue. These fractions were pooled arnd concentrated, glycerol was added to 25%, and the cytolysin was frozen at -70°C. Amino-terminal sequence determination of perfringolysin 0. The first 17 amino acids of purified perfringolysin 0 from C. perfringens and the first 10 residues from the perfringolysin 0 purified from E. coli were determined by sequence analysis on a model 470A gas-phase amino acid analyzer (Applied Biosystems, Foster City, Calif.), equipped with an on-line model 120A PTH analyzer, by following the manufacturer instructions.
Peptide mapping. High-resolution two-dimensional peptide mapping of cloned perfringolysin 0 gene product and authentic perfringolysin 0 was accomplished as previously described (17) . Briefly, perfringolysin 0 was labeled with 125I by using chloramine T and separated from excess 125I by SDS-PAGE. The gel was stained with Coomassie R-250 dye and dried onto porous cellulose (Bio-Rad Laboratories), and the stained cytolysin bands were excised. The dried gel slices were hydrated in a solution of 50 mM ammonium bicarbonate (pH 7.9) that contained 50 jig of TPCK (tosylamino-2-phenylethyl chloromethyl ketone)-treated trypsin (Sigma) per ml. The gel slices were incubated in this solution for 18 to 24 h at 37°C. The supematant fluid, which contained the tryptic peptides, was separated from the gel fragments and lyophilized. The pellet was suspended in electrophoresis buffer (acetic acid-formic acid-H20, 3:1:16) to which 2 R1 of a 0.1% solution pyronin Y dye was added. The labeled peptides (1 x 106 to 2 x 106 cpm) were spotted onto the corner of a sheet of chromogram cellulose (20 cm by 20 cm; Eastman Kodak Co., Rochester, N.Y.), and the plate was wetted with electrophoresis buffer. The tryptic peptides were separated by electrophoresis at a constant 500 V at 5°C on a FBE-3000 flatbed electrophoresis system (Pharmacia). The plate was dried and turned 90 degrees, and the peptides were chromatographed in a mixture of 1-butanol-pyridineacetic acid-H20 (32.5:25:5:37.5). Peptide spots were visualized following exposure of the chromatogram to X-ray film for 24 to 36 h at -70°C.
RESULTS
Cloning of the perfringolysin 0 gene in E. coli. Two chromosomal libraries were constructed from the C. perfringens chromosomal DNA; one was constructed from BclIdigested DNA, and the other was from EcoRI-digested DNA. Only the library constructed from the BclI-cut DNA yielded plaques which exhibited a zone of hemolysis when the plates were overlaid with blood agar containing DTT. Formation of hemolytic zones by these clones was abolished when cholesterol was included in the blood agar overlay. The hemolytic clones formed small plaques and upon amplification underwent rearrangements at a high frequency (#10-2), which resulted in derivatives that formed larger, normal-sized plaques. Several derivatives remained hemolytic, and one, designated XRT1, was chosen for further analysis. Digestion of the XRT1 DNA with Sall, an enzyme which cut on both sides of the cloning site of EMBL3, showed that XRT1 carried a 14-kilobase insert. The lysate proteins from a large-scale batch culture of the recombinant phage XRT1 were concentrated, separated by SDS-PAGE, and blotted to nitrocellulose. When the nitrocellulose blot was probed with antibody to perfringolysin 0, a band was identified that comigrated with authentic perfringolysin 0 (data not shown).
The XRT1 DNA was partially digested with Sau3Al and ligated to plasmid pKIM2 (Fig. 1) , a derivative of the low-copy-number plasmid pACYC184, into which the multiple cloning site and the lacZ gene fragment from pUC19 had been cloned (M. Gilmore, unpublished data). Recombinants carrying the perfringolysin 0 gene were identified by the formation of hemolytic zones around the colonies. One recombinant, pRT8, contained a 7.2-kilobase fragment which could be excised by digestion of the plasmid with SstI and SphI; neither enzyme cut within the insert. A further reduction in the size of the insert was accomplished by cutting the plasmid at the SstI site and digesting it with BAL 31 (Fig. 1) . The plasmid was cut at the SphI site, the ends were filled in with DNA polymerase (large fragment), and the fragments were ligated into SmaI-digested pUC19. Recombinants were plated on media containing ampicillin and 3% human erythrocytes. Those recombinants which still produced an active hemolysin were identified, and the insert size was determined by digesting the plasmids with SphI and SstI. One hemolytic clone, designated pRTlB (Fig. 1) , was identified that contained a 3.2-kilobase fragment. This recombinant was selected for further analysis of the pfo and its product. Restriction analysis and deletion experiments indicated that the toxin gene was located proximal to the pUC19 polylinker SphI restriction endonuclease site (Fig. 1) .
Localization of thepfo gene product in E. coli. The location of the pfo product in E. coli was determined by separating the subcellular fractions and analyzing each for hemolytic activity. An overnight culture of pRTlB was diluted into 250 ml of fresh culture media, with or without 1 mM IPTG, and grown for 18 h at 37°C with vigorous aeration. The various subcellular fractions were separated, and each fraction was analyzed for hemolytic activity. Approximately 86% of the hemolytic activity was found in the periplasm (Table 1) , as was the case for the periplasmic enzyme alkaline phosphatase. The cold osmotic procedure did not lyse a significant number of cells, since less than 1% of the cyoplasmic enzyme pyruvate dehydrogenase was present in the periplasmic extract. It was likely that all of the functional perfringolysin 0 was secreted to the periplasm, since the amount of perfringolysin 0 in the cytoplasmic fraction was likely due to the efficiency of the osmotic shock procedure rather than a truly cytoplasmic species. As the incubation time of these cultures increased, particularly in the presence of IPTG, greater levels of the cytolysin were found in the supernatant fluid, probably due to cellular lysis rather than a specific transport process. This observation was supported by the fact that cells grown in the presence of IPTG, which produced four-to fivefold more perfringolysin 0 than uninduced cells, were osmotically fragile. Simply washing the cells with TE buffer released much of the hemolytic activity.
Purification and characterization of the pfo product. A significant level of hemolytic activity was present in periplasmic extracts of E. coli which contained pRT1B. It was estimated that this recombinant produced approximately 20 mg of perfringolysin 0 per liter of culture when induced with IPTG (Table 1) . From a 1-liter culture of this recombinant, approximately 15 mg of pure perfringolysin 0 was isolated from a periplasmic extract. During the purification, the pfo product exhibited elution characteristics identical to those of authentic perfringolysin 0 when chromatographed on highresolution gel filtration and ion-exchange columns (data not shown). When analyzed by SDS-PAGE (Fig. 2) , the pfo product comigrated with authentic perfringolysin 0, and both had an estimated molecular weight of 54,000. The authentic perfringolysin 0 and pfo product also exhibited similar hemolytic activities on sheep erythrocytes (Fig. 3) . One HU of either authentic or recombinant-derived cytolysin was equivalent to 1 ng and corresponded to 106 HU per mg. One HU lysed approximately 5.5 x 105 sheep erythrocytes and was comparable to about 2 x 104 molecules of the cytolysin per erythrocyte. The hemolytic activity of both authentic and cloned gene products also exhibited similar pH and temperature stability optimums (data not shown). Both proteins exhibited maximum stability at an incubation time of 60 min, at pH 7.0, and at temperatures between 0 and 22°C. At temperatures of 55°C and greater, both proteins were completely inactivated. These values are similar to those determined by Mitsui et al. (7) for perfringolysin 0.
The amino-terminal sequences of the authentic perfringolysin 0 and that purified from the E. coli clone were determined (Fig. 4) . Both proteins were found to have identical amino-terminal sequences which, in view of the periplasmic location of the toxin, justifies the contention that perfringolysin 0 was transported and the putative signal peptide cleaved correctly by E. coli. In addition, OhnoIwashita et al. (10) have also determined the amino-terminal sequence of perfringolysin 0 purified from C. perfringens PB6K. Their data shows that all three sequences correspond closely, although at least two differences are apparent at residues 2 and 6 between the data presented here and that of Ohno-Iwashita et al. (10) . Assuming that all three sequences are correct, these data indicate that sequence differences are present in perfringolysin 0 derived from different strains of C. perfringens. Yamakawa et al. (19) determined the aminoterminal residue for perfringolysin 0 (also from C. perfringens PB6K) to be lysine, which also corresponded with the amino-terminal residue determined in this study.
The tryptic peptides derived from the pfo product (Fig.  5A) were identical to those of authentic perfringolysin 0 (Fig. SB) , which provided strong evidence that both proteins were identical in their primary structures. The peptide maps also confirm that there were no contaminating proteins which comigrated with either preparation of perfringolysin 0, since contaminating proteins would The expression of undegraded product in this clone facilitated the purification of usable quantities of the pfo-encoded perfringolysin 0. The purified pfo product and authentic perfringolysin 0 exhibited the same molecular weight when analyzed by SDS-PAGE and had similar hemolytic activities on sheep erythrocytes. The amino-terminal sequence of the recombinant-derived perfringolysin 0 was found to be identical to that for the authentic perfringolysin 0. Since perfringolysin 0 is secreted by C. perfringens, it is likely that it has a signal peptide which is cleaved off during secretion. Providing that perfringolysin 0 is produced with a signal peptide, these data confirm that the secretion apparatus of E. coli correctly processed perfringolysin 0 during secretion.
These data support the contention that the secretory apparatus of C. perfringens is similar to that of E. coli. Both amino-terminal sequences were nearly identical to that determined for perfringolysin 0 by Ohno-Iwashita et al. (10) . In addition, secondary sequences were detected during the amino-terminal sequence analysis, which provides further evidence that both proteins were highly purified. Finally, the tryptic maps confirmed that there were no major differences between the primary structures of the pfo-encoded perfringolysin 0 and authentic perfringolysin 0. These results were important for two reasons. First, it was necessary to verify that the perfringolysin 0 gene had not been affected by rearrangements in the original bacteriophage X clone; second, it was necessary to determine whether the cloned gene product differed significantly from authentic perfringolysin 0 with respect to activity and physical characteristics. The fact that the peptide maps, amino-terminal sequences, and heritolytic activities of both authentic and cloned products are identical supports the conclusion that perfringolysin 0 produced by the cloned gene in E. coli is identical to that produced by C. perfringens.
Recently, Fairweather et al. (1) reported that they had cloned the gene for perfringolysin 0; however, there were some differences with the current findings. They reported the gene product to be approximately 49,000 daltons. The perfringolysin 0 was identified by the use of SLO antisera; however, no other criteria were used in the identification of the cloned gene product. The gene was also reported to be contained on a HindIII-EcoRI fragment. In contrast, the size of the perfringolysin 0 gene product reported here is approximately 54,000 daltons and the only Hindlll site in the present clone is internal to the perfringolysin 0 gene. They also reported an internal BamHI site, whereas no BamHI site has been detected in pfo in the present study. However, it should be noted that considerable discrepancies in the physical characteristics of perfringolysin 0 have been observed from different strains (for a review, see reference 14). The differences in these data suggest that differences may exist between the perfringolysin 0 genes from the various clostridial species (particularly from types A through E) or that more than one thiol-activated cytolysin may be produced by certain species of C. perfringens. This would not be unexpected, since the thiol-activated cytolysins from Streptococcus pyogenes (SLO) and Streptococcus pneumoniae (pneumolysin) exhibited less than 45% homology in their primary sequences (5, 18) . The results reported here confirm that the perfringolysin 0 gene has been cloned, that the gene product has been correctly processed and secreted in E. coli, and that the major gene product was comparable to perfringolysin 0 produced by C. perfringens in all aspects examined. Recently, the genes for streptolysin 0 (4) and pneumolysin (11, 18) were cloned in E. coli and sequenced (5, 18) . Therefore, direct comparisons of the primary structures of these cytolysins can be made with that of perfringolysin 0 once the sequence of perfringolysin 0 has been determined.
